PANC OTC
Panacos Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -82.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume200
Avg Volume144
Beta-58.99
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJohn R. Barr
Employees41
SectorHealthcare
IndustryBiotechnology
IPO Date2005-03-14
Websitepanacos.com
134 Coolidge Avenue
Watertown, MA 02472
US
Watertown, MA 02472
US
617 926 1551
About Panacos Pharmaceuticals, Inc.
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fischer Laurent | A-Award | 15,000 | $0.59 | 2008-06-19 |
| LERNER IRWIN | A-Award | 15,000 | $0.59 | 2008-06-19 |
| FLETCHER R JOHN | A-Award | 15,000 | $0.59 | 2008-06-19 |
| Savage Robert G. | A-Award | 15,000 | $0.59 | 2008-06-19 |
| LIMBER JOSEPH M | A-Award | 15,000 | $0.59 | 2008-06-19 |